Navigation Links
febit Appoints Michelle Lyles, Ph.D., Vice President, Marketing and Sales
Date:3/10/2008

MEDFORD, Mass. and HEIDELBERG, Germany, March 10 /PRNewswire/ -- febit holding gmbh today announced the appointment of Michelle Lyles, Ph.D., to the newly created position of vice president, marketing and sales. She will be based in febit inc.'s U.S. headquarters, which is located near Boston in Medford, Mass.

Lyles will manage the US marketing and sales initiatives for febit's genomics technology products and services. These initiatives will include the company's launch of the Geniom(R) RT Analyzer, a fully automated instrument for the hybridization, washing, staining and scanning of microarrays, in the second quarter of this year.

"This is an exciting phase for febit, with the upcoming launch of the Geniom RT Analyzer," said Cord. F. Staehler, president and CEO of febit. "The addition of Michelle to the growing febit team is an important step -- in expanding our presence in the USA, the world's most important market for innovative genomics research products and services."

Lyles has extensive sales and marketing experience in the life sciences industry. Prior to joining febit, she was director of sales with Sigma-Aldrich Corp.'s research biotechnology business unit, where she successfully grew key businesses, built the sales team and created sales processes. Before this, Lyles was vice president of sales and marketing with Genospectra Inc. Earlier in her career, she was a technology manager for high-throughput screening (HTS) systems with PerkinElmer Inc., and product manager for the BioChip Array and sales development manager for HTS assay platforms with Packard Biosciences Co.

"I am thrilled to help bring febit's technology offering to full fruition by putting it in the hands of the life sciences research community," said Lyles. "febit's pioneering technology and team of highly experienced scientists position the company as a leader in genomics."

Lyles earned her Ph.D. in biochemistry at Baylor College of Medicine and completed post-doctoral training at Emory University. She holds a B.S. in biology and a B.S. in chemistry from the University of New Orleans.

About febit

febit enables scientists to read, write and understand the code of life: DNA. With its unique Geniom technology products and services, febit is the only company that puts the control for simplified genomics research directly into users' hands. Geniom exploits cutting-edge microarray technology for the analysis and synthesis of genes and genomes, providing superior time- and cost-efficiency combined with an unsurpassed spectrum of applications. Many world-renowned institutions and companies use Geniom today to drive their basic and applied research. For more information, visit http://www.febit.com.

Contact:

febit holding gmbh Russo Partners, LLC

Eva Sterzel David Schull or Wendy Lau

Public Relations Manager +1-212-845-4271

+49 (6221) 6510-300 david.schull@russopartnersllc.com

eva.sterzel@febit.de wendy.lau@russopartnersllc.com


'/>"/>
SOURCE febit
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Elusys Therapeutics Appoints Robert Gundel as Vice President of Research
2. Spectral appoints Anthony Bihl to Board of Directors
3. Tianyin Pharmaceutical Appoints Three New Independent Board Members
4. Hiemstra Appoints Robert C. Glines as Director of Business Development
5. Tengion Appoints Jeff Randall to Board of Directors
6. Ambrx Appoints Douglas Axelrod Senior Vice President for Clinical Research and Development
7. BioStorage Technologies Appoints Dr. Wolfgang Hoffer as Managing Director of European Operations
8. Stem Cell Company t2cure Appoints Dr Rueck Head of Clinical Operations
9. Human Genome Sciences Appoints Maxine Gowen, Ph.D., to Its Board Of Directors
10. ImmunoVaccine Technologies appoints the Honourable Michael Kirby as Chair
11. China Technology Appoints Deloitte Touche Tohmatsu CPA as Independent Auditor
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... June 27, 2016 /PRNewswire/ - BIOREM Inc. (TSX-V: BRM) ("Biorem" ... by its major shareholders, Clean Technology Fund I, LP ... States based venture capital funds which together ... (on a fully diluted, as converted basis), that they ... their entire equity holdings in Biorem to TUS Holdings ...
(Date:6/27/2016)... ... 2016 , ... Newly created 4Sight Medical Solutions ... healthcare market. The company's primary focus is on new product introductions, to include ... are necessary to help companies efficiently bring their products to market. , The ...
(Date:6/24/2016)... 2016  Regular discussions on a range of subjects including ... two entities said Poloz. Speaking at a lecture ... , he pointed to the country,s inflation target, which is ... "In certain areas there ... common economic goals, why not sit down and address strategy ...
(Date:6/23/2016)... WA (PRWEB) , ... June 23, 2016 , ... ... announces the release of its second eBook, “Clinical Trials Patient Recruitment and Retention ... recruitment and retention in this eBook by providing practical tips, tools, and strategies ...
Breaking Biology Technology:
(Date:6/2/2016)... 2016 The Department of Transport Management ... 44 million US Dollar project, for the , ... Personalization, Enrolment, and IT Infrastructure , to ... and implementation of Identity Management Solutions. Numerous renowned international vendors ... Decatur was selected for the most compliant and ...
(Date:5/20/2016)...  VoiceIt is excited to announce its new ... By working together, VoiceIt and VoicePass will offer ... take slightly different approaches to voice biometrics, collaboration ... usability. Both ... "This marketing and technology partnership allows ...
(Date:4/28/2016)... and BANGALORE, India , April 28, 2016 ... a product subsidiary of Infosys (NYSE: INFY ), ... a global partnership that will provide end customers ... mobile banking and payment services.      (Logo: ... innovation area for financial services, but it also plays a ...
Breaking Biology News(10 mins):